Conclusions: Our experience provides further evidence of the efficacy and safety of eptacog beta for surgical prophylaxis and treatment of bleeding in patients with haemophilia A with inhibitors, but also in those with factor VII deficiency. The gene discussed is F7; the disease is hyperinsulinemic hypoglycemia, familial, 4.